No Detail Found!

Evaluation of the efficacy of vitamin D combined with aspirin and immunoglobulin in treating children with the acute Kawasaki disease

Author(s)
Yuan Cheng Anhui Provincial Children's Hospital, Infectious Disease, Hefei 230000, Anhui, China
QingFeng Fang Anhui Provincial Children's Hospital, Infectious Disease, Hefei 230000, Anhui, China
BiQuan Chen Anhui Provincial Children's Hospital, Infectious Disease, Hefei 230000, Anhui, China
Abstract
The acute Kawasaki Disease (KD) is a pediatric condition that can cause significant cardiovascular damage, particularly affecting the coronary arteries. Recent research suggests that vitamin D regulates the immune responses and inflammation, potentially improving outcomes in KD. A randomized control trial involving 120 children aged 1-5 years assigned participants to either a treatment group (receiving intravenous immunoglobulin [IVIG], aspirin, and vitamin D; n=60) or a control group (receiving IVIG and aspirin only; n=60). Clinical symptoms, blood routine indices, and serum inflammatory markers (IL-1ß, IL-6, and TNF-a) were assessed before and after treatment. Compared to the control group, the treatment group exhibited significantly faster fever resolution (antipyretic time: 27.2±1.3 hours vs. 50.4±2.4 hours in the control group, p < 0.001), lower incidence of IVIG adverse reactions (19 cases vs. 8 cases in the control group, p = 0.031), and reduced levels of inflammatory markers (WBC, CRP, ESR and platelet count). Additionally, the treatment group had lower post-treatment levels of pro-inflammatory cytokines (IL-1ß, IL-6, and TNF-a). These findings suggest that vitamin D supplementation may modulate the immune response and improve clinical outcomes in children with KD.
Publication Details
Page(s) 1589-1592
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
Vitamin D, Pediatric, inflammation, intravenous immunoglobulin, aspirin, Kawasaki disease
References
Alphonse MP,Duong TT,Shumitzu C,Hoang TL,McCrindle BW,Franco A,Schurmans S,Philpott DJ,Hibberd ML,Burns J,Kuijpers TW,Yeung RS .2016 .Inositol-triphosphate 3-kinase C mediates inflammasome activation and treatment response in Kawasaki disease. J. Immunol., 197(9) : 3481-3489.
Bordea MA,Costache C,Grama A,Florian AI,Lupan I,Samasca G,Deleanu D,Makovicky P,Makovicky P,Rimarova K P .2022 .Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome. Physiol. Res., 71(1) : 17-27.
Gatera VA,Lesmana R,Musfiroh I,Judistiani RTD,Setiabudiawan B,Abdulah R B .2021 .Vitamin D inhibits lipopolysaccharide (LPS)-induced inflammation in A549 cells by down regulating inflammatory cytokines. Basic Res., 27(1) : e931481.
Jindal AK,Pilania RK,Prithvi A,Guleria S,Singh S S .2019 .Kawasaki disease: Characteristics, diagnosis, and unusual presentations. Expert Rev. Clin. Immunol, 15(10) : 1089-1104.
Jun JS,Jung YK,Lee DW .2017 .Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease. Korean J. Pediatr., 60(7) : 216-220.
Lopez DV,Al-Jaberi FAH,Woetmann A,Odum N,Bonefeld CM,Kongsbak-Wismann M,Geisler C M .2021 .Macrophages control the bioavailability of vitamin D and vitamin D-regulated T cell responses. Front. Immunol., 12(9) : 722806.
Marriaga-Nunez B,Arellano-Valdez A,Paz JPA,BonalPerez MA,Montano-Duron JG,Solorzano-Santos F .2023 .Immunoglobulin-resistant Kawasaki disease. Bol. Med, 80(4) : 260-264.
Pal E,Ungvari Z,Benyo Z,Varbiro S Z .2023 .Role of vitamin D deficiency in the pathogenesis of cardiovascular and cerebrovascular diseases. Nutrients, 15(2) : 334.
Porritt RA,Chase Huizar C,Dick EJ,Kumar S,Escalona R,Gomez AC,Marek-Iannucci S,Noval Rivas M,Patterson J,Forsthuber TG,Arditi M,Gorelik M M .2021 .Inhibition of IL-6 in the LCWE mouse model of Kawasaki disease inhibits acute phase reactant serum amyloid a but fails to attenuate vasculitis. Front. Immunol., 12(9) : 630196.
Gedalia Rife E,A Rife E .2020 .. Kawasaki Disease: An Update. Curr. Rheumatol. Rep, 22(10) : 75.
Sakurai Y .2019 .Autoimmune Aspects of Kawasaki Disease. J. Investig. Allergol. Clin. Immunol, 29(4) : 251-261.
Sedaghat K,Naderian R,Pakdel R,Bandegi AR,Ghods Z AR .2021 .Regulatory effect of vitamin D on proinflammatory cytokines and anti-oxidative enzymes dysregulations due to chronic mild stress in the rat hippocampus and prefrontal cortical area. Mol. Biol. Rep, 48(12) : 7865-7873.
Sheikh V,Kasapoglu P,Zamani A,Basiri Z,TahamoliRoudsari A,Alahgholi-Hajibehzad M .2018 .Vitamin D3 inhibits the proliferation of T helper cells, downregulate CD4(+) T cell cytokines and upregulate inhibitory markers. Hum. Immunol., 79(6) : 439-445.
Stagi S,Rigante D,Lepri G,Matucci Cerinic M and Falcini F G .2016 .Severe vitamin D deficiency in patients with Kawasaki disease: A potential role in the risk to develop heart vascular abnormalities? Clin. , 35(7) : 1865-1872.
Tan Z,Yuan Y,Chen S,Chen Y,Chen TX Y .2013 .Plasma Endothelial Microparticles, TNF-a and IL-6 in Kawasaki Disease. , 50(5) : 501-503.
0

Citations

0

Downloads

63

Views